Muzammal Hussain, Aqeel Javeed, Muhammad Ashraf, Samerene Siddique, Amjad Riaz, Muhammad Mahmood Mukhtar
The transcription factor-based therapeutic approaches are the mainstay of current anticancer drug design options to develop highly selective agents with novel modes of action